F. Al-Nasser

Beta-blocking in heart failure patients. Balancing the evidence.

M. Piepoli, M. G. Marinone, F. Al-Nasser, 2001, International journal of cardiology.

High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients.

S. Anker, M. Cicoira, C. Davos, 2001, Cytokine.

Beta-blocker therapy for dynamic left-ventricular outflow tract obstruction.

S. Anker, A. Coats, M. Henein, 2002, International journal of cardiology.

Effect of carvedilol on exercise tolerance in patients with chronic heart failure and a restrictive left ventricular filling pattern.

P. Ponikowski, S. Anker, A. Coats, 2003, The American journal of cardiology.

The importance of tumor necrosis factor and lipoproteins in the pathogenesis of chronic heart failure.

S. Anker, R. Sharma, F. Al-Nasser, 2001, Heart failure monitor.

Chronic heart failure as a metabolic disorder.

S. Anker, F. Al-Nasser, F. O. Al-Nasser, 2000, Heart failure monitor.

Beta-blockers for chronic heart failure: surviving longer but feeling better?

A. Bolger, F. Al-Nasser, F. Al-Nasser, 2003, International journal of cardiology.

Femoral haemostasis after transcatheter therapeutic intervention: a prospective randomised study of the angio-seal device vs. the femostop device.

A. Coats, R. Stables, U. Sigwart, 2000, International journal of cardiology.